The Effect of Perioperative Transcutaneous Electrical Acupoint Stimulation Combined With T
Protocol Summary Project Name:Effect of Perioperative TEAS Combined with TCM on Gastrointestinal Function Recovery in Abdominal Surgery Patients Research Objective:To evaluate the impact of perioperative TEAS combined with TCM on postoperative gastrointestinal function, pain, adverse reactions, hospital stay, and compl
| Condition(s) | ERAS, Traditional Chinese Medication (TCM) |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Protocol Summary Project Name:Effect of Perioperative TEAS Combined with TCM on Gastrointestinal Function Recovery in Abdominal Surgery Patients Research Objective:To evaluate the impact of perioperative TEAS combined with TCM on postoperative gastrointestinal function, pain, adverse reactions, hospital stay, and complications, as well as its safety, aiming to enrich the ERAS and prehabilitation theory and promote the integration of TCM in surgical practice. Research Design:Prospective, randomized, open-label trial involving 148 abdominal surgery patients (Grade IV surgeries) randomly assigned 1:1 to the experimental group (TCM + TEAS + prehabilitation + ERAS) or the control group (prehabilitation + ERAS). Total Cases:148 Case Selection Inclusion Criteria: 1. Age 18-80, no severe gastroint |
| Who can participate | Inclusion Criteria: * Patients aged \>18 years with no severe preoperative gastrointestinal dysfunction (e.g., no chronic gastrointestinal diseases such as long-term constipation or diarrhea). * Scheduled abdominal Grade IV surgeries (limited to liver, gallbladder, pancreas, stomach, or intestinal procedures) performed via open or laparoscopic approach. * Preoperative American Society of Anesthesiologists (ASA) Physical Status Classification of I-III. * Patients and their families fully understand the study's purpose, methods, potential risks/benefits, and provide signed informed consent. Exclusion Criteria: * Comorbid severe systemic diseases. * Local skin abnormalities at acupoints (e.g.,broken skin, infection, allergies, or scarring). * Preoperative long-term use (\>1 month) of gastroin |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Lead sponsor | Guang'anmen Hospital of China Academy of Chinese Medical Sciences |
| Locations | Beijing, Beijing Municipality, China |
| Start date | 2025-09-01 |
| NCT ID | NCT07081802 |
| Official listing | https://clinicaltrials.gov/study/NCT07081802 |